The role of caspase-2 in stress-induced apoptosis

Journal of Cellular and Molecular Medicine

Volumn 14, Issue 6 A, 2010, Pages 1212-1224

  Bouchier Hayes, Lisa ^a  

^a ST JUDE CHILDREN S RESEARCH HOSPITAL   (United States)

Author keywords

Apoptosis; Caspase 2; PIDD; RAIDD; Tumour suppressor

Indexed keywords

CASPASE 2;

ANIMAL; APOPTOSIS; ENZYME ACTIVATION; GENERAL ASPECTS OF DISEASE; HUMAN; METABOLISM; PHYSIOLOGICAL STRESS; REVIEW; DISEASES;

ANIMALS; APOPTOSIS; CASPASE 2; DISEASE; ENZYME ACTIVATION; HUMANS; STRESS, PHYSIOLOGICAL;

MUS;

EID: 77955135238     PISSN: 15821838     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1582-4934.2010.01037.x     Document Type: Review

References (131)

1. Taylor RC, Cullen SP, Martin SJ. Apoptosis: controlled demolition at the cellular level. Nat Rev Mol Cell Biol. 2008, 9:231-41.
2. Creagh EM, Conroy H, Martin SJ. Caspase-activation pathways in apoptosis and immunity. Immunol Rev. 2003, 193:10-21.
3. Howley B, Fearnhead HO. Caspases as therapeutic targets. J Cell Mol Med. 2008, 12:1502-16.
4. Boatright KM, Salvesen GS. Mechanisms of caspase activation. Curr Opin Cell Biol. 2003, 15:725-31.
5. Ferraro E, Corvaro M, Cecconi F. Physiological and pathological roles of Apaf1 and the apoptosome. J Cell Mol Med. 2003, 7:21-34.
6. Boldin MP, Goncharov TM, Goltsev YV. Involvement of MACH, a novel MORT1/FADD-interacting protease, in Fas/APO-1- and TNF receptor-induced cell death. Cell. 1996, 85:803-15.
7. Luo X, Budihardjo I, Zou H. Bid, a Bcl2 interacting protein, mediates cytochrome c release from mitochondria in response to activation of cell surface death receptors. Cell. 1998, 94:481-90.
8. Boatright KM, Renatus M, Scott FL. A unified model for apical caspase activation. Mol Cell. 2003, 11:529-41.
9. Salvesen GS, Dixit VM. Caspase activation: the induced-proximity model. Proc Natl Acad Sci USA. 1999, 96:10964-7.
10. Salvesen GS, Riedl SJ. Caspase mechanisms. Adv Exp Med Biol. 2008, 615:13-23.
11. Lamkanfi M, Declercq W, Kalai M. Alice in caspase land. A phylogenetic analysis of caspases from worm to man. Cell Death Differ. 2002, 9:358-61.
12. Thornberry NA, Rano TA, Peterson EP. A combinatorial approach defines specificities of members of the caspase family and granzyme B. Functional relationships established for key mediators of apoptosis. J Biol Chem. 1997, 272:17907-11.
13. Talanian RV, Quinlan C, Trautz S. Substrate specificities of caspase family proteases. J Biol Chem. 1997, 272:9677-82.
14. Aravind L, Dixit VM, Koonin EV. The domains of death: evolution of the apoptosis machinery. Trends Biochem Sci. 1999, 24:47-53.
15. Hofmann K, Bucher P, Tschopp J. The CARD domain: a new apoptotic signalling motif. Trends Biochem Sci. 1997, 22:155-6.
16. Read SH, Baliga BC, Ekert PG. A novel Apaf-1-independent putative caspase-2 activation complex. J Cell Biol. 2002, 159:739-45.
17. Xue D, Shaham S, Horvitz HR. The Caenorhabditis elegans cell-death protein CED-3 is a cysteine protease with substrate specificities similar to those of the human CPP32 protease. Genes Dev. 1996, 10:1073-83.
18. Butt AJ, Harvey NL, Parasivam G. Dimerization and autoprocessing of the Nedd2 (caspase-2) precursor requires both the prodomain and the carboxyl-terminal regions. J Biol Chem. 1998, 273:6763-8.
19. Baliga BC, Read SH, Kumar S. The biochemical mechanism of caspase-2 activation. Cell Death Differ. 2004, 11:1234-41.
20. Karki P, Dahal GR, Shin SY. Efficient cleavage of Bid and procaspase-7 by caspase-2 at lower pH. Protein Pept Lett. 2008, 15:1044-9.
21. Guo Y, Srinivasula SM, Druilhe A. Caspase-2 induces apoptosis by releasing proapoptotic proteins from mitochondria. J Biol Chem. 2002, 277:13430-7.
22. Bonzon C, Bouchier-Hayes L, Pagliari LJ. Caspase-2-induced apoptosis requires bid cleavage: a physiological role for bid in heat shock-induced death. Mol Biol Cell. 2006, 17:2150-7.
23. Bouchier-Hayes L, Oberst A, McStay GP. Characterization of cytoplasmic caspase-2 activation by induced proximity. Mol Cell. 2009, 35:830-40.
24. Tu S, McStay GP, Boucher LM. In situ trapping of activated initiator caspases reveals a role for caspase-2 in heat shock-induced apoptosis. Nat Cell Biol. 2006, 8:72-7.
25. Slee EA, Harte MT, Kluck RM. Ordering the cytochrome c-initiated caspase cascade: hierarchical activation of caspases-2, -3, -6, -7, -8, and -10 in a caspase-9-dependent manner. J Cell Biol. 1999, 144:281-92.
26. O'Reilly LA, Ekert P, Harvey N. Caspase-2 is not required for thymocyte or neuronal apoptosis even though cleavage of caspase-2 is dependent on both Apaf-1 and caspase-9. Cell Death Differ. 2002, 9:832-41.
27. Franklin EE, Robertson JD. Requirement of Apaf-1 for mitochondrial events and the cleavage or activation of all procaspases during genotoxic stress-induced apoptosis. Biochem J. 2007, 405:115-22.
28. Bergeron L, Perez GI, Macdonald G. Defects in regulation of apoptosis in caspase-2-deficient mice. Genes Dev. 1998, 12:1304-14.
29. Ranger AM, Malynn BA, Korsmeyer SJ. Mouse models of cell death. Nat Genet. 2001, 28:113-8.
30. Nutt LK, Margolis SS, Jensen M. Metabolic regulation of oocyte cell death through the CaMKII-mediated phosphorylation of caspase-2. Cell. 2005, 123:89-103.
31. Zhang Y, Padalecki SS, Chaudhuri AR. Caspase-2 deficiency enhances aging-related traits in mice. Mech Ageing Dev. 2007, 128:213-21.
32. Ho LH, Taylor R, Dorstyn L. A tumor suppressor function for caspase-2. Proc Natl Acad Sci USA. 2009, 106:5336-41.
33. Shi M, Vivian CJ, Lee KJ. DNA-PKcs-PIDDosome: a nuclear caspase-2-activating complex with role in G2/M checkpoint maintenance. Cell. 2009, 136:508-20.
34. Mancini M, Machamer CE, Roy S. Caspase-2 is localized at the Golgi complex and cleaves golgin-160 during apoptosis. J Cell Biol. 2000, 149:603-12.
35. Maag RS, Mancini M, Rosen A. Caspase-resistant Golgin-160 disrupts apoptosis induced by secretory pathway stress and ligation of death receptors. Mol Biol Cell. 2005, 16:3019-27.
36. Guha M, Xia F, Raskett CM. Caspase 2-mediated tumor suppression involves survivin gene silencing. Oncogene. 2009, 10.1038/onc.2009.428, doi
37. Hsu H, Huang J, Shu HB. TNF-dependent recruitment of the protein kinase RIP to the TNF receptor-1 signaling complex. Immunity. 1996, 4:387-96.
38. Janssens S, Tinel A, Lippens S. PIDD mediates NF-kappaB activation in response to DNA damage. Cell. 2005, 123:1079-92.
39. Altieri DC. Survivin, cancer networks and pathway-directed drug discovery. Nat Rev Cancer. 2008, 8:61-70.
40. Dahal GR, Karki P, Thapa A. Caspase-2 cleaves DNA fragmentation factor (DFF45)/inhibitor of caspase-activated DNase (ICAD). Arch Biochem Biophys. 2007, 468:134-9.
41. Gu Y, Sarnecki C, Aldape RA. Cleavage of poly(ADP-ribose) polymerase by interleukin-1 beta converting enzyme and its homologs TX and Nedd-2. J Biol Chem. 1995, 270:18715-8.
42. Condorelli F, Salomoni P, Cotteret S. Caspase cleavage enhances the apoptosis-inducing effects of BAD. Mol Cell Biol. 2001, 21:3025-36.
43. Truscott M, Denault JB, Goulet B. Carboxyl-terminal proteolytic processing of CUX1 by a caspase enables transcriptional activation in proliferating cells. J Biol Chem. 2007, 282:30216-26.
44. Panaretakis T, Laane E, Pokrovskaja K. Doxorubicin requires the sequential activation of caspase-2, protein kinase Cdelta, and c-Jun NH2-terminal kinase to induce apoptosis. Mol Biol Cell. 2005, 16:3821-31.
45. Kitevska T, Spencer DM, Hawkins CJ. Caspase-2: controversial killer or checkpoint controller. Apoptosis. 2009, 14:829-48.
46. Krumschnabel G, Manzl C, Villunger A. Caspase-2: killer, savior and safeguard-emerging versatile roles for an ill-defined caspase. Oncogene. 2009, 28:3093-6.
47. Krumschnabel G, Sohm B, Bock F. The enigma of caspase-2: the laymen's view. Cell Death Differ. 2009, 16:195-207.
48. Lassus P, Opitz-Araya X, Lazebnik Y. Requirement for caspase-2 in stress-induced apoptosis before mitochondrial permeabilization. Science. 2002, 297:1352-4.
49. Ho LH, Read SH, Dorstyn L. Caspase-2 is required for cell death induced by cytoskeletal disruption. Oncogene. 2008, 27:3393-404.
50. Upton JP, Austgen K, Nishino M. Caspase-2 cleavage of BID is a critical apoptotic signal downstream of endoplasmic reticulum stress. Mol Cell Biol. 2008, 28:3943-51.
51. Droin N, Bichat F, Rebe C. Involvement of caspase-2 long isoform in Fas-mediated cell death of human leukemic cells. Blood. 2001, 97:1835-44.
52. Troy CM, Stefanis L, Greene LA. Nedd2 is required for apoptosis after trophic factor withdrawal, but not superoxide dismutase (SOD1) downregulation, in sympathetic neurons and PC12 cells. J Neurosci. 1997, 17:1911-8.
53. Troy CM, Rabacchi SA, Friedman WJ. Caspase-2 mediates neuronal cell death induced by beta-amyloid. J Neurosci. 2000, 20:1386-92.
54. McStay GP, Salvesen GS, Green DR. Overlapping cleavage motif selectivity of caspases: implications for analysis of apoptotic pathways. Cell Death Differ. 2008, 15:322-31.
55. Schweizer A, Roschitzki-Voser H, Amstutz P. Inhibition of caspase-2 by a designed ankyrin repeat protein: specificity, structure, and inhibition mechanism. Structure. 2007, 15:625-36.
56. Manzl C, Krumschnabel G, Bock F. Caspase-2 activation in the absence of PIDDosome formation. J Cell Biol. 2009, 185:291-303.
57. Lakhani SA, Masud A, Kuida K. Caspases 3 and 7: key mediators of mitochondrial events of apoptosis. Science. 2006, 311:847-51.
58. Kuida K, Zheng TS, Na S. Decreased apoptosis in the brain and premature lethality in CPP32-deficient mice. Nature. 1996, 384:368-72.
59. Stefanis L, Troy CM, Qi H. Caspase-2 (Nedd-2) processing and death of trophic factor-deprived PC12 cells and sympathetic neurons occur independently of caspase-3 (CPP32)-like activity. J Neurosci. 1998, 18:9204-15.
60. Troy CM, Rabacchi SA, Hohl JB. Death in the balance: alternative participation of the caspase-2 and -9 pathways in neuronal death induced by nerve growth factor deprivation. J Neurosci. 2001, 21:5007-16.
61. Garcia-Calvo M, Peterson EP, Leiting B. Inhibition of human caspases by peptide-based and macromolecular inhibitors. J Biol Chem. 1998, 273:32608-13.
62. Shyu YJ, Liu H, Deng X. Identification of new fluorescent protein fragments for bimolecular fluorescence complementation analysis under physiological conditions. Biotechniques. 2006, 40:61-6.
63. Hu CD, Chinenov Y, Kerppola TK. Visualization of interactions among bZIP and Rel family proteins in living cells using bimolecular fluorescence complementation. Mol Cell. 2002, 9:789-98.
64. Schmidt C, Peng B, Li Z. Mechanisms of proinflammatory cytokine-induced biphasic NF-kappaB activation. Mol Cell. 2003, 12:1287-300.
65. Milleron RS, Bratton SB. Heat shock induces apoptosis independently of any known initiator caspase-activating complex. J Biol Chem. 2006, 281:16991-7000.
66. Moulin M, Arrigo AP. Caspases activation in hyperthermia-induced stimulation of TRAIL apoptosis. Cell Stress Chaperones. 2008, 13:313-26.
67. Pagliari LJ, Kuwana T, Bonzon C. The multidomain proapoptotic molecules Bax and Bak are directly activated by heat. Proc Natl Acad Sci USA. 2005, 102:17975-80.
68. Cippitelli M, Fionda C, Di Bona D. Hyperthermia enhances CD95-ligand gene expression in T lymphocytes. J Immunol. 2005, 174:223-32.
69. Tinel A, Tschopp J. The PIDDosome, a protein complex implicated in activation of caspase-2 in response to genotoxic stress. Science. 2004, 304:843-6.
70. Duan H, Dixit VM. RAIDD is a new 'death' adaptor molecule. Nature. 1997, 385:86-9.
71. Park HH, Logette E, Raunser S. Death domain assembly mechanism revealed by crystal structure of the oligomeric PIDDosome core complex. Cell. 2007, 128:533-46.
72. Baliga BC, Colussi PA, Read SH. Role of prodomain in importin-mediated nuclear localization and activation of caspase-2. J Biol Chem. 2003, 278:4899-905.
73. Colussi PA, Harvey NL, Kumar S. Prodomain-dependent nuclear localization of the caspase-2 (Nedd2) precursor. A novel function for a caspase prodomain. J Biol Chem. 1998, 273:24535-42.
74. Paroni G, Henderson C, Schneider C. Caspase-2 can trigger cytochrome C release and apoptosis from the nucleus. J Biol Chem. 2002, 277:15147-61.
75. Kim IR, Murakami K, Chen NJ. DNA damage- and stress-induced apoptosis occurs independently of PIDD. Apoptosis. 2009, 14:1039-49.
76. Berube C, Boucher LM, Ma W. Apoptosis caused by p53-induced protein with death domain (PIDD) depends on the death adapter protein RAIDD. Proc Natl Acad Sci USA. 2005, 102:14314-20.
77. Lavrik IN, Golks A, Baumann S. Caspase-2 is activated at the CD95 death-inducing signaling complex in the course of CD95-induced apoptosis. Blood. 2006, 108:559-65.
78. Olsson M, Vakifahmetoglu H, Abruzzo PM. DISC-mediated activation of caspase-2 in DNA damage-induced apoptosis. Oncogene. 2009, 28:1949-59.
79. Sanchez-Pulido L, Valencia A, Rojas AM. Are promyelocytic leukaemia protein nuclear bodies a scaffold for caspase-2 programmed cell death. Trends Biochem Sci. 2007, 32:400-6.
80. Tang J, Xie W, Yang X. Association of caspase-2 with the promyelocytic leukemia protein nuclear bodies. Cancer Biol Ther. 2005, 4:645-9.
81. Hofmann TG, Will H. Body language: the function of PML nuclear bodies in apoptosis regulation. Cell Death Differ. 2003, 10:1290-9.
82. McMillan DR, Xiao X, Shao L. Targeted disruption of heat shock transcription factor 1 abolishes thermotolerance and protection against heat-inducible apoptosis. J Biol Chem. 1998, 273:7523-8.
83. Xiao X, Zuo X, Davis AA. HSF1 is required for extra-embryonic development, postnatal growth and protection during inflammatory responses in mice. EMBO J. 1999, 18:5943-52.
84. Beere HM, Wolf BB, Cain K. Heat-shock protein 70 inhibits apoptosis by preventing recruitment of procaspase-9 to the Apaf-1 apoptosome. Nat Cell Biol. 2000, 2:469-75.
85. Saleh A, Srinivasula SM, Balkir L. Negative regulation of the Apaf-1 apoptosome by Hsp70. Nat Cell Biol. 2000, 2:476-83.
86. Pandey P, Saleh A, Nakazawa A. Negative regulation of cytochrome c-mediated oligomerization of Apaf-1 and activation of procaspase-9 by heat shock protein 90. EMBO J. 2000, 19:4310-22.
87. Nutt LK, Buchakjian MR, Gan E. Metabolic control of oocyte apoptosis mediated by 14-3-3zeta-regulated dephosphorylation of caspase-2. Dev Cell. 2009, 16:856-66.
88. Andersen JL, Johnson CE, Freel CD. Restraint of apoptosis during mitosis through interdomain phosphorylation of caspase-2. EMBO J. 2009, 28:3216-27.
89. Shin S, Lee Y, Kim W. Caspase-2 primes cancer cells for TRAIL-mediated apoptosis by processing procaspase-8. EMBO J. 2005, 24:3532-42.
90. Wang L, Miura M, Bergeron L. Ich-1, an Ice/ced-3-related gene, encodes both positive and negative regulators of programmed cell death. Cell. 1994, 78:739-50.
91. Fushimi K, Ray P, Kar A. Up-regulation of the proapoptotic caspase 2 splicing isoform by a candidate tumor suppressor, RBM5. Proc Natl Acad Sci USA. 2008, 105:15708-13.
92. Sidi S, Sanda T, Kennedy RD. Chk1 suppresses a caspase-2 apoptotic response to DNA damage that bypasses p53, Bcl-2, and caspase-3. Cell. 2008, 133:864-77.
93. Kumar S, White DL, Takai S. Apoptosis regulatory gene NEDD2 maps to human chromosome segment 7q34-35, a region frequently affected in haematological neoplasms. Hum Genet. 1995, 95:641-4.
94. Mitelman F, Kaneko Y, Trent JM. Report of the committee on chromosome changes in neoplasia. Cytogenet Cell Genet. 1990, 55:358-86.
95. Holleman A, den Boer ML, Kazemier KM. Decreased PARP and procaspase-2 protein levels are associated with cellular drug resistance in childhood acute lymphoblastic leukemia. Blood. 2005, 106:1817-23.
96. Hofmann WK, de Vos S, Tsukasaki K. Altered apoptosis pathways in mantle cell lymphoma detected by oligonucleotide microarray. Blood. 2001, 98:787-94.
97. Estrov Z, Thall PF, Talpaz M. Caspase 2 and caspase 3 protein levels as predictors of survival in acute myelogenous leukemia. Blood. 1998, 92:3090-7.
98. Faderl S, Thall PF, Kantarjian HM. Caspase 2 and caspase 3 as predictors of complete remission and survival in adults with acute lymphoblastic leukemia. Clin Cancer Res. 1999, 5:4041-7.
99. Shimohama S, Tanino H, Fujimoto S. Changes in caspase expression in Alzheimer's disease: comparison with development and aging. Biochem Biophys Res Commun. 1999, 256:381-4.
100. Majumder P, Raychaudhuri S, Chattopadhyay B. Increased caspase-2, calpain activations and decreased mitochondrial complex II activity in cells expressing exogenous huntingtin exon 1 containing CAG repeat in the pathogenic range. Cell Mol Neurobiol. 2007, 27:1127-45.
101. Hermel E, Gafni J, Propp SS. Specific caspase interactions and amplification are involved in selective neuronal vulnerability in Huntington's disease. Cell Death Differ. 2004, 11:424-38.
102. Qin Y, Vanden Hoek TL, Wojcik K. Caspase-dependent cytochrome c release and cell death in chick cardiomyocytes after simulated ischemia-reperfusion. Am J Physiol Heart Circ Physiol. 2004, 286:H2280-6.
103. Koseki T, Inohara N, Chen S. ARC, an inhibitor of apoptosis expressed in skeletal muscle and heart that interacts selectively with caspases. Proc Natl Acad Sci USA. 1998, 95:5156-60.
104. Zhang YQ, Herman B. ARC protects rat cardiomyocytes against oxidative stress through inhibition of caspase-2 mediated mitochondrial pathway. J Cell Biochem. 2006, 99:575-88.
105. Kumar S, Vaux DL. Apoptosis. A cinderella caspase takes center stage. Science. 2002, 297:1290-1.
106. Robertson JD, Enoksson M, Suomela M. Caspase-2 acts upstream of mitochondria to promote cytochrome c release during etoposide-induced apoptosis. J Biol Chem. 2002, 277:29803-9.
107. Seth R, Yang C, Kaushal V. p53-dependent caspase-2 activation in mitochondrial release of apoptosis-inducing factor and its role in renal tubular epithelial cell injury. J Biol Chem. 2005, 280:31230-9.
108. Vakifahmetoglu H, Olsson M, Tamm C. DNA damage induces two distinct modes of cell death in ovarian carcinomas. Cell Death Differ. 2008, 15:555-66.
109. Vakifahmetoglu H, Olsson M, Orrenius S. Functional connection between p53 and caspase-2 is essential for apoptosis induced by DNA damage. Oncogene. 2006, 25:5683-92.
110. Baptiste-Okoh N, Barsotti A, Prives C. A role for caspase 2 and PIDD in the process of p53-mediated apoptosis. Proc Natl Acad Sci USA. 2008, 105:1937-42.
111. He Q, Huang Y, Sheikh MS. Bax deficiency affects caspase-2 activation during ultraviolet radiation-induced apoptosis. Oncogene. 2004, 23:1321-5.
112. Niizuma K, Endo H, Nito C. The PIDDosome mediates delayed death of hippocampal CA1 neurons after transient global cerebral ischemia in rats. Proc Natl Acad Sci USA. 2008, 105:16368-73.
113. Araya R, Uehara T, Nomura Y. Hypoxia induces apoptosis in human neuroblastoma SK-N-MC cells by caspase activation accompanying cytochrome c release from mitochondria. FEBS Lett. 1998, 439:168-72.
114. Haviv R, Lindenboim L, Yuan J. Need for caspase-2 in apoptosis of growth-factor-deprived PC12 cells. J Neurosci Res. 1998, 52:491-7.
115. Gu C, Casaccia-Bonnefil P, Srinivasan A. Oligodendrocyte apoptosis mediated by caspase activation. J Neurosci. 1999, 19:3043-9.
116. Cheung HH, Lynn Kelly N, Liston P. Involvement of caspase-2 and caspase-9 in endoplasmic reticulum stress-induced apoptosis: a role for the IAPs. Exp Cell Res. 2006, 312:2347-57.
117. Huang WC, Lin YS, Chen CL. Glycogen synthase kinase-3beta mediates endoplasmic reticulum stress-induced lysosomal apoptosis in leukemia. J Pharmacol Exp Ther. 2009, 329:524-31.
118. Gu H, Chen X, Gao G. Caspase-2 functions upstream of mitochondria in endoplasmic reticulum stress-induced apoptosis by bortezomib in human myeloma cells. Mol Cancer Ther. 2008, 7:2298-307.
119. Rahmani M, Davis EM, Crabtree TR. The kinase inhibitor sorafenib induces cell death through a process involving induction of endoplasmic reticulum stress. Mol Cell Biol. 2007, 27:5499-513.
120. Rosato RR, Almenara JA, Maggio SC. Role of histone deacetylase inhibitor-induced reactive oxygen species and DNA damage in LAQ-824/fludarabine antileukemic interactions. Mol Cancer Ther. 2008, 7:3285-97.
121. Peart MJ, Tainton KM, Ruefli AA. Novel mechanisms of apoptosis induced by histone deacetylase inhibitors. Cancer Res. 2003, 63:4460-71.
122. Calvino-Fernandez M, Benito-Martinez S, Parra-Cid T. Oxidative stress by Helicobacter pylori causes apoptosis through mitochondrial pathway in gastric epithelial cells. Apoptosis. 2008, 13:1267-80.
123. Tamm C, Zhivotovsky B, Ceccatelli S. Caspase-2 activation in neural stem cells undergoing oxidative stress-induced apoptosis. Apoptosis. 2008, 13:354-63.
124. Zafar KS, Inayat-Hussain SH, Ross D. A comparative study of proteasomal inhibition and apoptosis induced in N27 mesencephalic cells by dopamine and MG132. J Neurochem. 2007, 102:913-21.
125. Wagner KW, Engels IH, Deveraux QL. Caspase-2 can function upstream of bid cleavage in the TRAIL apoptosis pathway. J Biol Chem. 2004, 279:35047-52.
126. Werner AB, Tait SW, de Vries E. Requirement for aspartate-cleaved bid in apoptosis signaling by DNA-damaging anti-cancer regimens. J Biol Chem. 2004, 279:28771-80.
127. Paroni G, Henderson C, Schneider C. Caspase-2-induced apoptosis is dependent on caspase-9, but its processing during UV- or tumor necrosis factor-dependent cell death requires caspase-3. J Biol Chem. 2001, 276:21907-15.
128. Chen F, He Y. Caspase-2 mediated apoptotic and necrotic murine macrophage cell death induced by rough Brucella abortus. PLoS One 2009, 4:e6830.
129. Mohan J, Gandhi AA, Bhavya BC. Caspase-2 triggers Bax-Bak-dependent and -independent cell death in colon cancer cells treated with resveratrol. J Biol Chem. 2006, 281:17599-611.
130. Shen J, Vakifahmetoglu H, Stridh H. PRIMA-1MET induces mitochondrial apoptosis through activation of caspase-2. Oncogene. 2008, 27:6571-80.
131. Chen W, Wang HG, Srinivasula SM. B cell apoptosis triggered by antigen receptor ligation proceeds via a novel caspase-dependent pathway. J Immunol. 1999, 163:2483-91.